• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation.

作者信息

Rouby Jean-Jacques, Monsel Antoine, Leone Marc, Mimoz Olivier, Laterre Pierre-François, Pugin Jérôme

机构信息

Multidisciplinary Intensive Care Unit, Department of Anaesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique - Hôpitaux de Paris, Medicine Sorbonne University, Paris, France.

Multidisciplinary Intensive Care Unit, Department of Anaesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique - Hôpitaux de Paris, Medicine Sorbonne University, Paris, France.

出版信息

Anaesth Crit Care Pain Med. 2020 Apr;39(2):179-183. doi: 10.1016/j.accpm.2020.03.007. Epub 2020 Mar 7.

DOI:10.1016/j.accpm.2020.03.007
PMID:32156643
Abstract
摘要

相似文献

1
The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation.IASIS、INHALE和VAPORISE试验。三重失败的原因：研究设计、氨基糖苷类药物剂量及雾化技术。
Anaesth Crit Care Pain Med. 2020 Apr;39(2):179-183. doi: 10.1016/j.accpm.2020.03.007. Epub 2020 Mar 7.
2
Understanding the nebulisation of antibiotics: the key role of lung microdialysis studies.理解抗生素雾化吸入：肺微透析研究的关键作用。
Crit Care. 2024 Feb 19;28(1):49. doi: 10.1186/s13054-024-04828-z.
3
Aminoglycosides' dosing and monitoring practices in critically ill patients in Quebec hospitals.魁北克省医院重症患者氨基糖苷类药物的给药和监测实践。
J Chemother. 2022 Sep;34(5):341-344. doi: 10.1080/1120009X.2022.2040771. Epub 2022 Mar 3.
4
Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria.庆大霉素耐药革兰氏阴性菌对卡那霉素、妥布霉素、奈替米星和阿米卡星的耐药频率。
Antimicrob Agents Chemother. 1978 Jan;13(1):70-3. doi: 10.1128/AAC.13.1.70.
5
Aminoglycoside-induced nephrotoxicity.氨基糖苷类药物引起的肾毒性。
J Pharm Pract. 2014 Dec;27(6):573-7. doi: 10.1177/0897190014546836. Epub 2014 Sep 7.
6
Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review.治疗革兰氏阴性菌引起的医院获得性肺炎的抗生素肺部药代动力学：系统评价。
Int J Antimicrob Agents. 2019 Mar;53(3):234-245. doi: 10.1016/j.ijantimicag.2018.11.011. Epub 2018 Nov 23.
7
Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.新型氨基糖苷类抗生素和羧苄青霉素单独及联合使用时对庆大霉素耐药铜绿假单胞菌的活性。
Antimicrob Agents Chemother. 1976 Sep;10(3):399-401. doi: 10.1128/AAC.10.3.399.
8
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.优化抗假单胞菌抗生素治疗囊性纤维化肺部加重：五、氨基糖苷类。
Pediatr Pulmonol. 2013 Nov;48(11):1047-61. doi: 10.1002/ppul.22813. Epub 2013 Sep 2.
9
Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.药物及给药方案的选择。氨基糖苷类药物肾毒性的两个重要风险因素。
Am J Med. 1986 Jun 30;80(6B):115-8. doi: 10.1016/0002-9343(86)90488-2.
10
[The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].丁胺卡那霉素与其他三种氨基糖苷类抗生素的抗菌活性比较（作者译）
Med Klin. 1978 Jun 16;73(24):914-7.

引用本文的文献

1
Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review.医院获得性肺炎需更新的十个问题：专家综述
J Clin Med. 2023 Oct 14;12(20):6526. doi: 10.3390/jcm12206526.
2
Aerosolised antibiotics in critical care.重症监护中的雾化抗生素。
Intensive Care Med. 2023 Jul;49(7):848-852. doi: 10.1007/s00134-023-07036-5. Epub 2023 Apr 21.
3
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia.吸入性阿米卡星治疗肺炎并预防播散：严重单侧铜绿假单胞菌肺炎的实验模型。
Crit Care. 2023 Feb 14;27(1):60. doi: 10.1186/s13054-023-04331-x.
4
Pharmacokinetic Characteristics of Nebulized Colistimethate Sodium Using Two Different Types of Nebulizers in Critically Ill Patients with Ventilator-Associated Respiratory Infections.在患有呼吸机相关性呼吸道感染的重症患者中使用两种不同类型雾化器雾化多粘菌素甲磺酸钠的药代动力学特征
Antibiotics (Basel). 2022 Nov 1;11(11):1528. doi: 10.3390/antibiotics11111528.
5
Aerosolized polymyxins for ventilator-associated pneumonia caused by extensive drug resistant Gram-negative bacteria: class, dose and manner should remain the trifecta.用于治疗广泛耐药革兰氏阴性菌引起的呼吸机相关性肺炎的雾化多粘菌素：类别、剂量和方式应仍是关键三要素。
Ann Intensive Care. 2022 Oct 17;12(1):97. doi: 10.1186/s13613-022-01068-8.
6
Therapeutic drug monitoring of amikacin: quantification in plasma by liquid chromatography-tandem mass spectrometry and work experience of clinical pharmacists.阿米卡星的治疗药物监测：液相色谱-串联质谱法测定血浆中的浓度及临床药师的工作经验。
Eur J Hosp Pharm. 2022 Mar;29(e1):e77-e82. doi: 10.1136/ejhpharm-2021-003049. Epub 2021 Nov 17.
7
Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives.雾化吸入多黏菌素治疗呼吸机相关性肺炎和气管支气管炎：历史背景、药代动力学及展望
Microorganisms. 2021 May 27;9(6):1154. doi: 10.3390/microorganisms9061154.